Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CONSTELLATION PHARMACEUTICALS INC (CNST) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/26/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
07/23/2021 4/A Hoerter Steven L. (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 26,342 options to buy @ $9.05, valued at $238.4k
07/19/2021 4 Humphrey Jeffrey (Chief Medical Officer) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 133,000 options to buy @ $30.2, valued at $4M
Disposed/sold 35,055 options to buy @ $35.5, valued at $1.2M
07/19/2021 4 Valentine Karen (See Remarks) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 58,600 options to buy @ $35.5, valued at $2.1M
Disposed/sold 81,939 options to buy @ $11.5, valued at $942.3k
Disposed/sold 22,425 options to buy @ $8.76, valued at $196.4k
Disposed/sold 41,800 options to buy @ $36.06, valued at $1.5M
07/19/2021 4 Trehu Elizabeth (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 13,171 options to buy @ $37.52, valued at $494.2k
Disposed/sold 13,171 options to buy @ $9.12, valued at $120.1k
Disposed/sold 26,342 options to buy @ $9.05, valued at $238.4k
Disposed/sold 13,171 options to buy @ $33.57, valued at $442.2k
07/19/2021 4 Trojer Patrick (Chief Scientific Officer) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 72,050 options to buy @ $35.5, valued at $2.6M
Disposed/sold 22,708 options to buy @ $11.5, valued at $261.1k
Disposed/sold 78,000 options to buy @ $8.76, valued at $683.3k
Disposed/sold 43,387 options to buy @ $8.04, valued at $348.8k
Disposed/sold 850 options to buy @ $7.6, valued at $6.5k
Disposed/sold 33,330 options to buy @ $7.6, valued at $253.3k
Disposed/sold 40,000 options to buy @ $5.74, valued at $229.6k
Disposed/sold 17,312 options to buy @ $5.51, valued at $95.4k
Disposed/sold 3,121 options to buy @ $5.51, valued at $17.2k
Disposed/sold 55,000 options to buy @ $36.06, valued at $2M
07/19/2021 4 Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 60,000 options to buy @ $36.06, valued at $2.2M
Disposed/sold 37,527 options to buy @ $11.5, valued at $431.6k
Disposed/sold 73,428 options to buy @ $8.76, valued at $643.2k
Disposed/sold 11,777 options to buy @ $8.04, valued at $94.7k
Disposed/sold 17,666 options to buy @ $7.6, valued at $134.3k
Disposed/sold 80,971 options to buy @ $6.61, valued at $535.2k
Disposed/sold 66,950 options to buy @ $35.5, valued at $2.4M
07/19/2021 4 Raythatha Jigar (See Remarks) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 14,961 shares @ $0
Disposed/sold 200,000 options to buy @ $36.06, valued at $7.2M
Disposed/sold 306,938 options to buy @ $11.5, valued at $3.5M
Disposed/sold 245,000 options to buy @ $8.76, valued at $2.1M
Disposed/sold 141,929 options to buy @ $8.04, valued at $1.1M
Disposed/sold 141,929 options to buy @ $7.6, valued at $1.1M
Disposed/sold 423,940 options to buy @ $5.51, valued at $2.3M
Disposed/sold 204,500 options to buy @ $35.5, valued at $7.3M
07/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2021 4 GOLDSMITH MARK A (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 89,857 shares @ $0
Disposed/sold 13,171 options to buy @ $33.57, valued at $442.2k
Disposed/sold 6,825 options to buy @ $11.5, valued at $78.5k
Disposed/sold 13,171 options to buy @ $9.12, valued at $120.1k
Disposed/sold 12,446 options to buy @ $7.6, valued at $94.6k
Disposed/sold 9,083 options to buy @ $5.51, valued at $50k
Disposed/sold 13,171 options to buy @ $37.52, valued at $494.2k
07/19/2021 4 Braunstein Scott (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 13,171 options to buy @ $33.57, valued at $442.2k
Disposed/sold 26,342 options to buy @ $10.81, valued at $284.8k
Disposed/sold 13,171 options to buy @ $37.52, valued at $494.2k
07/19/2021 4 Audia James E (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 25,434 shares @ $0
Disposed/sold 13,171 options to buy @ $33.57, valued at $442.2k
Disposed/sold 8,175 options to buy @ $11.5, valued at $94k
Disposed/sold 13,171 options to buy @ $9.12, valued at $120.1k
Disposed/sold 1,277 options to buy @ $7.6, valued at $9.7k
Disposed/sold 9,083 options to buy @ $7.6, valued at $69k
Disposed/sold 24,604 options to buy @ $5.62, valued at $138.3k
Disposed/sold 2,384 options to buy @ $5.51, valued at $13.1k
Disposed/sold 9,083 options to buy @ $5.51, valued at $50k
Disposed/sold 11,626 options to buy @ $4.08, valued at $47.4k
Disposed/sold 13,171 options to buy @ $37.52, valued at $494.2k
07/19/2021 4 Levy Richard S (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Disposed/sold 13,171 options to buy @ $33.57, valued at $442.2k
Disposed/sold 26,342 options to buy @ $30.29, valued at $797.9k
07/19/2021 EFFECT Form EFFECT - Notice of Effectiveness:
07/15/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/15/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/15/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/15/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/15/2021 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
07/15/2021 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
07/15/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/15/2021 8-K Resignation/termination of a director
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Amended and Restated Certificate of Incorporation of Constellation Pharmaceuticals, Inc",
"Amended and Restated Bylaws of Constellation Pharmaceuticals, Inc"
07/15/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/15/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/15/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/16/2021 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
06/16/2021 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Braunstein Scott (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Granted 13,171 options to buy @ $33.57, valued at $442.2k
06/04/2021 4 GOLDSMITH MARK A (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Granted 13,171 options to buy @ $33.57, valued at $442.2k
06/04/2021 4 Trehu Elizabeth (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Granted 13,171 options to buy @ $33.57, valued at $442.2k
06/04/2021 4 Hoerter Steven L. (Director) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Granted 13,171 options to buy @ $33.57, valued at $442.2k
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy